Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Colorcon
AstraZeneca
Fish and Richardson
Harvard Business School
Julphar
Argus Health
US Department of Justice
Deloitte

Generated: October 22, 2017

DrugPatentWatch Database Preview

Alza Company Profile

« Back to Dashboard

What is the competitive landscape for ALZA, and when can generic versions of ALZA drugs launch?

ALZA has five approved drugs.

There are two US patents protecting ALZA drugs.

There are two patent family members on ALZA drugs in two countries and one supplementary protection certificate in one country.

Summary for Applicant: Alza

International Patents:2
US Patents:2
Tradenames:5
Ingredients:4
NDAs:5
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alza
EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE
brompheniramine maleate; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL019672-001Mar 29, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Alza
PROGESTASERT
progesterone
INSERT, EXTENDED RELEASE;INTRAUTERINE017553-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alza
TESTODERM TTS
testosterone
FILM, EXTENDED RELEASE;TRANSDERMAL020791-001Dec 18, 1997DISCNNoNo► Subscribe► Subscribe ► Subscribe
Alza
TESTODERM
testosterone
FILM, EXTENDED RELEASE;TRANSDERMAL019762-001Oct 12, 1993DISCNNoNo► Subscribe► Subscribe ► Subscribe
Alza
EFIDAC 24 CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate
TABLET, EXTENDED RELEASE;ORAL019746-002Nov 18, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Alza
TESTODERM
testosterone
FILM, EXTENDED RELEASE;TRANSDERMAL019762-002Oct 12, 1993DISCNNoNo► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Alza

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alza
TESTODERM
testosterone
FILM, EXTENDED RELEASE;TRANSDERMAL019762-001Oct 12, 1993► Subscribe► Subscribe
Alza
EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE
brompheniramine maleate; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL019672-001Mar 29, 1996► Subscribe► Subscribe
Alza
EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE
brompheniramine maleate; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL019672-001Mar 29, 1996► Subscribe► Subscribe
Alza
EFIDAC 24 CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate
TABLET, EXTENDED RELEASE;ORAL019746-002Nov 18, 1994► Subscribe► Subscribe
Alza
TESTODERM
testosterone
FILM, EXTENDED RELEASE;TRANSDERMAL019762-002Oct 12, 1993► Subscribe► Subscribe
Alza
EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE
brompheniramine maleate; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL019672-001Mar 29, 1996► Subscribe► Subscribe
Alza
TESTODERM
testosterone
FILM, EXTENDED RELEASE;TRANSDERMAL019762-002Oct 12, 1993► Subscribe► Subscribe
Alza
EFIDAC 24 CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate
TABLET, EXTENDED RELEASE;ORAL019746-002Nov 18, 1994► Subscribe► Subscribe
Alza
TESTODERM TTS
testosterone
FILM, EXTENDED RELEASE;TRANSDERMAL020791-001Dec 18, 1997► Subscribe► Subscribe
Alza
EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE
brompheniramine maleate; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL019672-001Mar 29, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Alza Drugs

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)9706789► Subscribe
Australia6853596► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Alza Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0037Belgium► SubscribePRODUCT NAME: OESTROGENES EQUINS CONJUGUES; ACETATE DE MEDROXYPROGESTERONE; NAT. REGISTRATION NO/DATE: NL 19569 19950301; FIRST REGISTRATION: CH - 52647 01 010 19940826
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Federal Trade Commission
Chinese Patent Office
Fuji
Express Scripts
Baxter
Johnson and Johnson
McKesson
Moodys
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot